|Articles|August 3, 2010

Quintiles' New Health Report

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!

Related Content

© JHVEPhoto - © JHVEPhoto - stock.adobe.com

Former FDA Commissioners Warn New Vaccine Policies Could Undermine Longstanding Regulatory Framework

ByAndy Studna, Senior Editor

December 4th 2025

ACT Brief: Targeted Trial Growth, Site Startup Strains, and Leadership Shake-Up at FDA

ByAndy Studna, Senior Editor

December 4th 2025

CNS and Autoimmune Trials: Growth and Operational Implications

ByHeidi Chen,Andy Studna, Senior Editor

December 4th 2025

© Andrii Yalanskyi - © Andrii Yalanskyi - stock.adobe.com

New ICON Survey Shows Sites Face Growing Delays and Communication Gaps During Study Startup

ByAndy Studna, Senior Editor

December 3rd 2025

Targeted and Strategy-Driven Clinical Development

ByHeidi Chen,Andy Studna, Senior Editor

December 3rd 2025

Quintiles' New Health Report

Newsletter

Related Content

Former FDA Commissioners Warn New Vaccine Policies Could Undermine Longstanding Regulatory Framework

ACT Brief: Targeted Trial Growth, Site Startup Strains, and Leadership Shake-Up at FDA

CNS and Autoimmune Trials: Growth and Operational Implications

New ICON Survey Shows Sites Face Growing Delays and Communication Gaps During Study Startup

Targeted and Strategy-Driven Clinical Development

Trending on Applied Clinical Trials Online

New ICON Survey Shows Sites Face Growing Delays and Communication Gaps During Study Startup

CNS and Autoimmune Trials: Growth and Operational Implications

Targeted and Strategy-Driven Clinical Development

Voyxact Lands FDA Accelerated Approval Following Positive Results in Phase III VISIONARY Trial

How the FDA’s CNPV Program Is Reshaping Trial Operations and Accelerated Review Strategies